false
English
Catalog
Air Pollution and the Risk of Lung Cancer Webinar
Air Pollution and Risk of Lung Cancer - Recording
Air Pollution and Risk of Lung Cancer - Recording
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The ISLAC webinar on air pollution and lung cancer was moderated by Dr. Christine Berg and featured presentations from global experts including Dr. Michelle Turner, Dr. David Lam, Dr. Teha Suri, and Andrea Burundi-Kitz. Air pollution, the second leading cause of lung cancer, was discussed in terms of its sources, health impacts, and strategies for mitigation. Dr. Turner explained the carcinogenic nature of outdoor air pollution, referencing a significant 2013 IARC report, which classified it as a Group 1 human carcinogen primarily causing lung cancer. New studies further confirm increased cancer risk linked to PM2.5, even at low concentrations.<br /><br />Dr. Lam highlighted Asia's significant air pollution challenges, attributing both ambient and indoor pollution to lung cancer in the region. He shared promising policy actions in China aimed at reducing emissions. Dr. Suri focused on India, detailing its severe air pollution situation, sources, health effects, and the nation's various legislative and judicial measures to combat the issue, including the National Clean Air Programme.<br /><br />Andrea Burundi-Kitz outlined the healthcare sector’s role in air pollution contribution and mitigation. She emphasized reducing healthcare's carbon footprint, protecting patients from exposure, building resilience to climate events, and advocacy for green policies. <br /><br />The Q&A session addressed potential biomarkers for personal PM2.5 exposure and incorporating air pollution exposure into lung cancer risk prediction models. The session underscored the ongoing research and strategies needed for effective risk predictions and mitigation efforts. The webinar concluded with a call to action for healthcare professionals to actively engage in climate advocacy and protective measures for patient health.
Asset Subtitle
Video
Keywords
air pollution
lung cancer
Dr. Christine Berg
carcinogen
PM2.5
Asia
National Clean Air Programme
healthcare sector
biomarkers
climate advocacy
×
Please select your language
1
English
5
普通话
11
Dutch